Skip to main content

Closed

QURE: uniQure N.V. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+71.2% / yr

Operating margin-1089.1%

ROIC-22.5%

Financially safe

Stretched

Debt / equity0.42×

Interest coverage-3.4×

Current ratio10.40×

uniQure N.V.

QURENASDAQ·USD·Closed

uniQure N.V.

QURENASDAQ·USD·Closed

$43.63

+3.41%

$43.63

+$1.44 (3.41%)

52W Range

56thpctl

Volume

0.78×avg

Mkt Cap

3.03BUSD

P/E

-10.8TTM

Div Yield

–ann

52W Range

56thpctl

Volume

0.78×avg

Market Cap

3.03BUSD

P/E Ratio

-10.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings